PL4157832T3 - Sól i postacie krystaliczne agonistów GLP-1R oraz ich zastosowania - Google Patents
Sól i postacie krystaliczne agonistów GLP-1R oraz ich zastosowaniaInfo
- Publication number
- PL4157832T3 PL4157832T3 PL21733318.6T PL21733318T PL4157832T3 PL 4157832 T3 PL4157832 T3 PL 4157832T3 PL 21733318 T PL21733318 T PL 21733318T PL 4157832 T3 PL4157832 T3 PL 4157832T3
- Authority
- PL
- Poland
- Prior art keywords
- glp
- agonists
- salt
- crystal forms
- crystal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/22—Tricarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020092530 | 2020-05-27 | ||
| PCT/US2021/034191 WO2021242817A1 (en) | 2020-05-27 | 2021-05-26 | Salt and crystal forms of glp-1r agonists and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4157832T3 true PL4157832T3 (pl) | 2024-12-16 |
Family
ID=76502864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21733318.6T PL4157832T3 (pl) | 2020-05-27 | 2021-05-26 | Sól i postacie krystaliczne agonistów GLP-1R oraz ich zastosowania |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230203023A1 (pl) |
| EP (1) | EP4157832B1 (pl) |
| JP (1) | JP7702973B2 (pl) |
| CN (1) | CN115867546B (pl) |
| AU (1) | AU2021281237A1 (pl) |
| CA (1) | CA3179890A1 (pl) |
| DK (1) | DK4157832T3 (pl) |
| ES (1) | ES2985435T3 (pl) |
| FI (1) | FI4157832T3 (pl) |
| HU (1) | HUE068535T2 (pl) |
| PL (1) | PL4157832T3 (pl) |
| PT (1) | PT4157832T (pl) |
| WO (1) | WO2021242817A1 (pl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113227068B (zh) * | 2018-11-22 | 2023-06-13 | 上海齐鲁锐格医药研发有限公司 | Glp-1r激动剂及其用途 |
| JP7558267B2 (ja) | 2019-10-25 | 2024-09-30 | ギリアード サイエンシーズ， インコーポレイテッド | Ｇｌｐ－１ｒ調節化合物 |
| SI4097097T1 (sl) | 2020-01-29 | 2025-04-30 | Gilead Sciences, Inc. | Spojine, ki modulirajo glp-1r |
| US11851419B2 (en) | 2020-11-20 | 2023-12-26 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| US12180197B2 (en) | 2021-03-11 | 2024-12-31 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| US12091404B2 (en) | 2021-03-11 | 2024-09-17 | Gilead Sciences, Inc. | GLP-1R modulating compounds |
| EP4317145A4 (en) | 2021-03-24 | 2025-03-12 | Shionogi & Co., Ltd | Pharmaceutical composition containing glp-1 receptor agonist having fused ring |
| CA3216163A1 (en) | 2021-04-21 | 2022-10-27 | Gilead Sciences, Inc. | Carboxy-benzimidazole glp-1r modulating compounds |
| CA3224598A1 (en) | 2021-08-30 | 2023-03-09 | Long Zhang | Novel aryl ether substituted heterocyclic compound as glp1r agonist |
| US20240374587A1 (en) | 2021-09-08 | 2024-11-14 | Shionogi & Co., Ltd. | Medicine for prevention and treatment of diseases linked to anti-obesity activity |
| EP4408840B1 (en) | 2021-09-27 | 2025-08-13 | Terns Pharmaceuticals, Inc. | Benzimidazole carboxylic acids as glp-1r agonists |
| CN118401519A (zh) | 2021-10-25 | 2024-07-26 | 拓臻制药公司 | 作为glp-1r激动剂的化合物 |
| TW202328115A (zh) * | 2021-12-23 | 2023-07-16 | 大陸商江蘇恒瑞醫藥股份有限公司 | Glp-1受體激動劑的結晶形式及其製備方法 |
| US12410163B2 (en) | 2022-02-23 | 2025-09-09 | Terns Pharmaceuticals, Inc. | Compounds as GLP-IR agonists |
| CN117362282A (zh) * | 2022-07-07 | 2024-01-09 | 杭州德睿智药科技有限公司 | Glp-1r激动剂的盐及其制备方法和应用 |
| WO2024017266A1 (zh) * | 2022-07-18 | 2024-01-25 | 德睿智药(苏州)新药研发有限公司 | 一种glp-1r激动剂的多晶型物及其制备方法与用途 |
| CN119907794A (zh) | 2022-09-22 | 2025-04-29 | 盐野义制药株式会社 | 具有glp-1受体激动剂作用的稠环化合物 |
| US20240398794A1 (en) | 2023-04-07 | 2024-12-05 | Terns Pharmaceuticals, Inc. | COMBINATIONS OF GLP-1R AND THRß AGONISTS AND METHODS OF USE THEREOF |
| WO2025057134A2 (en) | 2023-09-14 | 2025-03-20 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| US12291530B1 (en) | 2023-11-24 | 2025-05-06 | Ascletis Pharma (China) Co., Limited | GLP-1R agonist and therapeutic method thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| CR20190289A (es) | 2016-12-16 | 2019-08-21 | Pfizer | Agonistas receptores de glp-1 y usos de los mismos |
| CN113227068B (zh) * | 2018-11-22 | 2023-06-13 | 上海齐鲁锐格医药研发有限公司 | Glp-1r激动剂及其用途 |
| TW202144340A (zh) * | 2020-04-03 | 2021-12-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 稠合咪唑類衍生物、其製備方法及其在醫藥上的應用 |
| CN111978313B (zh) * | 2020-08-28 | 2022-01-18 | 深圳大学 | 具备聚集诱导发光性质的多模态光诊疗剂及其制备与应用 |
-
2021
- 2021-05-26 PL PL21733318.6T patent/PL4157832T3/pl unknown
- 2021-05-26 ES ES21733318T patent/ES2985435T3/es active Active
- 2021-05-26 WO PCT/US2021/034191 patent/WO2021242817A1/en not_active Ceased
- 2021-05-26 CN CN202180041199.0A patent/CN115867546B/zh active Active
- 2021-05-26 US US17/927,502 patent/US20230203023A1/en active Pending
- 2021-05-26 JP JP2022572686A patent/JP7702973B2/ja active Active
- 2021-05-26 CA CA3179890A patent/CA3179890A1/en active Pending
- 2021-05-26 DK DK21733318.6T patent/DK4157832T3/da active
- 2021-05-26 EP EP21733318.6A patent/EP4157832B1/en active Active
- 2021-05-26 PT PT217333186T patent/PT4157832T/pt unknown
- 2021-05-26 FI FIEP21733318.6T patent/FI4157832T3/fi active
- 2021-05-26 AU AU2021281237A patent/AU2021281237A1/en active Pending
- 2021-05-26 HU HUE21733318A patent/HUE068535T2/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP7702973B2 (ja) | 2025-07-04 |
| CA3179890A1 (en) | 2021-12-02 |
| CN115867546B (zh) | 2024-10-18 |
| EP4157832A1 (en) | 2023-04-05 |
| HUE068535T2 (hu) | 2025-01-28 |
| TW202210473A (zh) | 2022-03-16 |
| ES2985435T3 (es) | 2024-11-05 |
| JP2023527997A (ja) | 2023-07-03 |
| EP4157832B1 (en) | 2024-06-19 |
| PT4157832T (pt) | 2024-07-30 |
| CN115867546A (zh) | 2023-03-28 |
| DK4157832T3 (da) | 2024-09-23 |
| US20230203023A1 (en) | 2023-06-29 |
| WO2021242817A1 (en) | 2021-12-02 |
| FI4157832T3 (fi) | 2024-08-29 |
| AU2021281237A1 (en) | 2023-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL4157832T3 (pl) | Sól i postacie krystaliczne agonistów GLP-1R oraz ich zastosowania | |
| EP4228753C0 (en) | CRYSTALLINE FORMS OF GLP-1 R AGONISTS AND THEIR USES | |
| IL287472A (en) | Crystalline form of wee1 inhibitory compound and use thereof | |
| IL287128A (en) | glp-1r agonists and uses thereof | |
| EP3825309A4 (en) | LSD1 INHIBITOR SALT AND POLYMORPH THEREOF | |
| IL283322A (en) | glp-1r agonists and uses thereof | |
| ZA202007037B (en) | Crystal form of c-met inhibitor and salt form thereof and preparation method therefor | |
| IL277326A (en) | Polymorphs of calcium salts that suppress dihydroureoate dehydrogenase, and methods for their production | |
| SG11202001153RA (en) | Leucoindigo salt solution with very low content of aniline and method of making same | |
| IL292499A (en) | compressed siglec-9 ecd molecules and methods of using them | |
| ZA202003581B (en) | Crystal form of urat1 inhibitor, and preparation method therefor | |
| IL309469A (en) | Salt and crystal forms of epidermal growth factor receptor inhibitor | |
| IL288348A (en) | A method for the synthesis of a furoimidazopyridine compound, a crystalline form of a furoimidazopyridine compound, and a crystalline form of its salt | |
| PT3725786T (pt) | Forma cristalina e forma salina de inibidor de tgf-bri e método de preparação das mesmas | |
| IL308804A (en) | TREM2 agonistic biomarkers and methods of using them | |
| EP4249476A4 (en) | Salt of a benzothiazole compound, crystal form and use thereof | |
| PT3725791T (pt) | Sal que serve como inibidor de akt e seu cristal | |
| IL274274A (en) | Salt form and crystal form of compound as FGFR4 inhibitor and method of their preparation | |
| PT3441430T (pt) | Solução de sal de leucoíndigo com muito baixo conteúdo de anilina e método de fabrico | |
| EP4438606A4 (en) | NEW CRYSTALLINE FORM OF A NUCLEOSIDE COMPOUND AND ITS SALT | |
| EP3498704A4 (en) | LONG-ACTING DPP-IV INHIBITOR CRYSTAL AND ITS SALT | |
| ZA202101589B (en) | Crystal form of tri-cycle compound and application thereof | |
| GB2571229B (en) | Additives to reduce the crystallization temperature of brines and methods of use | |
| PT3441431T (pt) | Métodos de fabrico de soluções de sal leucoindigo com teor de anilina muito baixo | |
| EP4130004A4 (en) | SALT AND CRYSTALLINE FORMS OF FGFR4 INHIBITOR AND THEIR USES |